APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buprenorphine Hydrochloride Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Buprenorphine Hydrochloride Injection Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchBuprenorphine Hydrochloride Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Buprenorphine Hydrochloride Injection Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Buprenorphine Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buprenorphine Hydrochloride Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Buprenorphine Hydrochloride Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Buprenorphine Hydrochloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Buprenorphine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Buprenorphine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Buprenorphine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Buprenorphine Hydrochloride Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Buprenorphine Hydrochloride Injection market include Arevipharma, Faranshimi, Mallinckrodt, Micro Orgo Chem, Noramco, Resonance-labs, Rusan Pharma, Siegfried and Sun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Buprenorphine Hydrochloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Buprenorphine Hydrochloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Buprenorphine Hydrochloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Buprenorphine Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Buprenorphine Hydrochloride Injection Segment by Company

Arevipharma

Faranshimi

Mallinckrodt

Micro Orgo Chem

Noramco

Resonance-labs

Rusan Pharma

Siegfried

Sun Pharma

Unichemlabs

Sanofi

Teva

Johnson Matthey

Buprenorphine Hydrochloride Injection Segment by Type

0.3mg / mL

0.6mg / mL

Buprenorphine Hydrochloride Injection Segment by Application

Analgesic

Opioid Antagonist

Buprenorphine Hydrochloride Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Buprenorphine Hydrochloride Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Buprenorphine Hydrochloride Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Buprenorphine Hydrochloride Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Buprenorphine Hydrochloride Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buprenorphine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buprenorphine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buprenorphine Hydrochloride Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Buprenorphine Hydrochloride Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Buprenorphine Hydrochloride Injection industry.

Chapter 3: Detailed analysis of Buprenorphine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Buprenorphine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Buprenorphine Hydrochloride Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Buprenorphine Hydrochloride Injection Industry Trends Table 2. Buprenorphine Hydrochloride Injection Industry Drivers Table 3. Buprenorphine Hydrochloride Injection Industry Opportunities and Challenges Table 4. Buprenorphine Hydrochloride Injection Industry Restraints Table 5. Global Buprenorphine Hydrochloride Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Buprenorphine Hydrochloride Injection Revenue Share by Company (2021-2026) Table 7. Global Buprenorphine Hydrochloride Injection Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Buprenorphine Hydrochloride Injection Sales Volume Share by Company (2021-2026) Table 9. Global Buprenorphine Hydrochloride Injection Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Buprenorphine Hydrochloride Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Buprenorphine Hydrochloride Injection Key Company Manufacturing Base & Headquarters Table 12. Global Buprenorphine Hydrochloride Injection Company, Product Type & Application Table 13. Global Buprenorphine Hydrochloride Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Buprenorphine Hydrochloride Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.3mg / mL Table 18. Significant Companies of 0.6mg / mL Table 19. Global Buprenorphine Hydrochloride Injection Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Buprenorphine Hydrochloride Injection Sales Volume by Type (2021-2026) & (Kg) Table 21. Global Buprenorphine Hydrochloride Injection Sales Volume by Type (2027-2032) & (Kg) Table 22. Global Buprenorphine Hydrochloride Injection Sales Volume Share by Type (2021-2026) Table 23. Global Buprenorphine Hydrochloride Injection Sales Volume Share by Type (2027-2032) Table 24. Global Buprenorphine Hydrochloride Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Buprenorphine Hydrochloride Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Buprenorphine Hydrochloride Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Buprenorphine Hydrochloride Injection Sales Value Share by Type (2021-2026) Table 28. Global Buprenorphine Hydrochloride Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Analgesic Table 30. Significant Companies of Opioid Antagonist Table 31. Global Buprenorphine Hydrochloride Injection Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 32. Global Buprenorphine Hydrochloride Injection Sales Volume by Application (2021-2026) & (Kg) Table 33. Global Buprenorphine Hydrochloride Injection Sales Volume by Application (2027-2032) & (Kg) Table 34. Global Buprenorphine Hydrochloride Injection Sales Volume Share by Application (2021-2026) Table 35. Global Buprenorphine Hydrochloride Injection Sales Volume Share by Application (2027-2032) Table 36. Global Buprenorphine Hydrochloride Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Buprenorphine Hydrochloride Injection Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Buprenorphine Hydrochloride Injection Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Buprenorphine Hydrochloride Injection Sales Value Share by Application (2021-2026) Table 40. Global Buprenorphine Hydrochloride Injection Sales Value Share by Application (2027-2032) Table 41. Global Buprenorphine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 42. Global Buprenorphine Hydrochloride Injection Sales by Region (2021-2026) & (Kg) Table 43. Global Buprenorphine Hydrochloride Injection Sales Market Share by Region (2021-2026) Table 44. Global Buprenorphine Hydrochloride Injection Sales by Region (2027-2032) & (Kg) Table 45. Global Buprenorphine Hydrochloride Injection Sales Market Share by Region (2027-2032) Table 46. Global Buprenorphine Hydrochloride Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Buprenorphine Hydrochloride Injection Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Buprenorphine Hydrochloride Injection Sales Value Share by Region (2021-2026) Table 49. Global Buprenorphine Hydrochloride Injection Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Buprenorphine Hydrochloride Injection Sales Value Share by Region (2027-2032) Table 51. Global Buprenorphine Hydrochloride Injection Market Average Price (US$/Kg) by Region (2021-2026) Table 52. Global Buprenorphine Hydrochloride Injection Market Average Price (US$/Kg) by Region (2027-2032) Table 53. Global Buprenorphine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 54. Global Buprenorphine Hydrochloride Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Buprenorphine Hydrochloride Injection Sales by Country (2021-2026) & (Kg) Table 56. Global Buprenorphine Hydrochloride Injection Sales Market Share by Country (2021-2026) Table 57. Global Buprenorphine Hydrochloride Injection Sales by Country (2027-2032) & (Kg) Table 58. Global Buprenorphine Hydrochloride Injection Sales Market Share by Country (2027-2032) Table 59. Global Buprenorphine Hydrochloride Injection Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Buprenorphine Hydrochloride Injection Sales Value Market Share by Country (2021-2026) Table 61. Global Buprenorphine Hydrochloride Injection Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Buprenorphine Hydrochloride Injection Sales Value Market Share by Country (2027-2032) Table 63. Arevipharma Company Information Table 64. Arevipharma Business Overview Table 65. Arevipharma Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Arevipharma Buprenorphine Hydrochloride Injection Product Portfolio Table 67. Arevipharma Recent Development Table 68. Faranshimi Company Information Table 69. Faranshimi Business Overview Table 70. Faranshimi Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Faranshimi Buprenorphine Hydrochloride Injection Product Portfolio Table 72. Faranshimi Recent Development Table 73. Mallinckrodt Company Information Table 74. Mallinckrodt Business Overview Table 75. Mallinckrodt Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Mallinckrodt Buprenorphine Hydrochloride Injection Product Portfolio Table 77. Mallinckrodt Recent Development Table 78. Micro Orgo Chem Company Information Table 79. Micro Orgo Chem Business Overview Table 80. Micro Orgo Chem Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Micro Orgo Chem Buprenorphine Hydrochloride Injection Product Portfolio Table 82. Micro Orgo Chem Recent Development Table 83. Noramco Company Information Table 84. Noramco Business Overview Table 85. Noramco Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Noramco Buprenorphine Hydrochloride Injection Product Portfolio Table 87. Noramco Recent Development Table 88. Resonance-labs Company Information Table 89. Resonance-labs Business Overview Table 90. Resonance-labs Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Resonance-labs Buprenorphine Hydrochloride Injection Product Portfolio Table 92. Resonance-labs Recent Development Table 93. Rusan Pharma Company Information Table 94. Rusan Pharma Business Overview Table 95. Rusan Pharma Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Rusan Pharma Buprenorphine Hydrochloride Injection Product Portfolio Table 97. Rusan Pharma Recent Development Table 98. Siegfried Company Information Table 99. Siegfried Business Overview Table 100. Siegfried Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Siegfried Buprenorphine Hydrochloride Injection Product Portfolio Table 102. Siegfried Recent Development Table 103. Sun Pharma Company Information Table 104. Sun Pharma Business Overview Table 105. Sun Pharma Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Sun Pharma Buprenorphine Hydrochloride Injection Product Portfolio Table 107. Sun Pharma Recent Development Table 108. Unichemlabs Company Information Table 109. Unichemlabs Business Overview Table 110. Unichemlabs Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Unichemlabs Buprenorphine Hydrochloride Injection Product Portfolio Table 112. Unichemlabs Recent Development Table 113. Sanofi Company Information Table 114. Sanofi Business Overview Table 115. Sanofi Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Sanofi Buprenorphine Hydrochloride Injection Product Portfolio Table 117. Sanofi Recent Development Table 118. Teva Company Information Table 119. Teva Business Overview Table 120. Teva Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 121. Teva Buprenorphine Hydrochloride Injection Product Portfolio Table 122. Teva Recent Development Table 123. Johnson Matthey Company Information Table 124. Johnson Matthey Business Overview Table 125. Johnson Matthey Buprenorphine Hydrochloride Injection Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 126. Johnson Matthey Buprenorphine Hydrochloride Injection Product Portfolio Table 127. Johnson Matthey Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Buprenorphine Hydrochloride Injection Distributors List Table 131. Buprenorphine Hydrochloride Injection Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Buprenorphine Hydrochloride Injection Product Image Figure 2. Global Buprenorphine Hydrochloride Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buprenorphine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Buprenorphine Hydrochloride Injection Sales (2021-2032) & (Kg) Figure 5. Global Buprenorphine Hydrochloride Injection Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Buprenorphine Hydrochloride Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.3mg / mL Image Figure 10. 0.6mg / mL Image Figure 11. Global Buprenorphine Hydrochloride Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Buprenorphine Hydrochloride Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Buprenorphine Hydrochloride Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Buprenorphine Hydrochloride Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Buprenorphine Hydrochloride Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Buprenorphine Hydrochloride Injection Sales Value Share by Type (2021-2032) Figure 17. Analgesic Image Figure 18. Opioid Antagonist Image Figure 19. Global Buprenorphine Hydrochloride Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 20. Global Buprenorphine Hydrochloride Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Buprenorphine Hydrochloride Injection Sales Volume Share by Application (2021-2032) Figure 22. Global Buprenorphine Hydrochloride Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Buprenorphine Hydrochloride Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Buprenorphine Hydrochloride Injection Sales Value Share by Application (2021-2032) Figure 25. Global Buprenorphine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 26. Global Buprenorphine Hydrochloride Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Buprenorphine Hydrochloride Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Buprenorphine Hydrochloride Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Buprenorphine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 30. North America Buprenorphine Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Buprenorphine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Buprenorphine Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Buprenorphine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Buprenorphine Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Buprenorphine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 36. South America Buprenorphine Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Buprenorphine Hydrochloride Injection Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Buprenorphine Hydrochloride Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Buprenorphine Hydrochloride Injection Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Buprenorphine Hydrochloride Injection Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 0.3mg / mL
  • 0.6mg / mL
Applications
  • Analgesic
  • Opioid Antagonist
Companies covered
  • Arevipharma
  • Faranshimi
  • Mallinckrodt
  • Micro Orgo Chem
  • Noramco
  • Resonance-labs
  • Rusan Pharma
  • Siegfried
  • Sun Pharma
  • Unichemlabs
  • Sanofi
  • Teva
  • Johnson Matthey

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Buprenorphine Hydrochloride Injection Sales Value (2021-2032)
  4. 1.2.2 Global Buprenorphine Hydrochloride Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Buprenorphine Hydrochloride Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Buprenorphine Hydrochloride Injection Market Dynamics
  1. 2.1 Buprenorphine Hydrochloride Injection Industry Trends
  2. 2.2 Buprenorphine Hydrochloride Injection Industry Drivers
  3. 2.3 Buprenorphine Hydrochloride Injection Industry Opportunities and Challenges
  4. 2.4 Buprenorphine Hydrochloride Injection Industry Restraints
3 Buprenorphine Hydrochloride Injection Market by Company
  1. 3.1 Global Buprenorphine Hydrochloride Injection Company Revenue Ranking in 2025
  2. 3.2 Global Buprenorphine Hydrochloride Injection Revenue by Company (2021-2026)
  3. 3.3 Global Buprenorphine Hydrochloride Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Buprenorphine Hydrochloride Injection Average Price by Company (2021-2026)
  5. 3.5 Global Buprenorphine Hydrochloride Injection Company Ranking (2024-2026)
  6. 3.6 Global Buprenorphine Hydrochloride Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Buprenorphine Hydrochloride Injection Company Product Type and Application
  8. 3.8 Global Buprenorphine Hydrochloride Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Buprenorphine Hydrochloride Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Buprenorphine Hydrochloride Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Buprenorphine Hydrochloride Injection Market by Type
  1. 4.1 Buprenorphine Hydrochloride Injection Type Introduction
  2. 4.1.1 0.3mg / mL
  3. 4.1.2 0.6mg / mL
  4. 4.2 Global Buprenorphine Hydrochloride Injection Sales Volume by Type
  5. 4.2.1 Global Buprenorphine Hydrochloride Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Buprenorphine Hydrochloride Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Buprenorphine Hydrochloride Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Buprenorphine Hydrochloride Injection Sales Value by Type
  9. 4.3.1 Global Buprenorphine Hydrochloride Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Buprenorphine Hydrochloride Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Buprenorphine Hydrochloride Injection Sales Value Share by Type (2021-2032)
5 Buprenorphine Hydrochloride Injection Market by Application
  1. 5.1 Buprenorphine Hydrochloride Injection Application Introduction
  2. 5.1.1 Analgesic
  3. 5.1.2 Opioid Antagonist
  4. 5.2 Global Buprenorphine Hydrochloride Injection Sales Volume by Application
  5. 5.2.1 Global Buprenorphine Hydrochloride Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Buprenorphine Hydrochloride Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Buprenorphine Hydrochloride Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Buprenorphine Hydrochloride Injection Sales Value by Application
  9. 5.3.1 Global Buprenorphine Hydrochloride Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Buprenorphine Hydrochloride Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Buprenorphine Hydrochloride Injection Sales Value Share by Application (2021-2032)
6 Buprenorphine Hydrochloride Injection Regional Sales and Value Analysis
  1. 6.1 Global Buprenorphine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Buprenorphine Hydrochloride Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Buprenorphine Hydrochloride Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Buprenorphine Hydrochloride Injection Sales by Region (2027-2032)
  5. 6.3 Global Buprenorphine Hydrochloride Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Buprenorphine Hydrochloride Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Buprenorphine Hydrochloride Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Buprenorphine Hydrochloride Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Buprenorphine Hydrochloride Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Buprenorphine Hydrochloride Injection Sales Value (2021-2032)
  12. 6.6.2 North America Buprenorphine Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Buprenorphine Hydrochloride Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Buprenorphine Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Buprenorphine Hydrochloride Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Buprenorphine Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Buprenorphine Hydrochloride Injection Sales Value (2021-2032)
  21. 6.9.2 South America Buprenorphine Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Buprenorphine Hydrochloride Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Buprenorphine Hydrochloride Injection Sales Value Share by Country, 2025 VS 2032
7 Buprenorphine Hydrochloride Injection Country-level Sales and Value Analysis
  1. 7.1 Global Buprenorphine Hydrochloride Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Buprenorphine Hydrochloride Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Buprenorphine Hydrochloride Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Buprenorphine Hydrochloride Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Buprenorphine Hydrochloride Injection Sales by Country (2027-2032)
  6. 7.4 Global Buprenorphine Hydrochloride Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Buprenorphine Hydrochloride Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Buprenorphine Hydrochloride Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Buprenorphine Hydrochloride Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Buprenorphine Hydrochloride Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Buprenorphine Hydrochloride Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Arevipharma
  2. 8.1.1 Arevipharma Company Information
  3. 8.1.2 Arevipharma Business Overview
  4. 8.1.3 Arevipharma Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Arevipharma Buprenorphine Hydrochloride Injection Product Portfolio
  6. 8.1.5 Arevipharma Recent Developments
  7. 8.2 Faranshimi
  8. 8.2.1 Faranshimi Company Information
  9. 8.2.2 Faranshimi Business Overview
  10. 8.2.3 Faranshimi Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Faranshimi Buprenorphine Hydrochloride Injection Product Portfolio
  12. 8.2.5 Faranshimi Recent Developments
  13. 8.3 Mallinckrodt
  14. 8.3.1 Mallinckrodt Company Information
  15. 8.3.2 Mallinckrodt Business Overview
  16. 8.3.3 Mallinckrodt Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mallinckrodt Buprenorphine Hydrochloride Injection Product Portfolio
  18. 8.3.5 Mallinckrodt Recent Developments
  19. 8.4 Micro Orgo Chem
  20. 8.4.1 Micro Orgo Chem Company Information
  21. 8.4.2 Micro Orgo Chem Business Overview
  22. 8.4.3 Micro Orgo Chem Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Micro Orgo Chem Buprenorphine Hydrochloride Injection Product Portfolio
  24. 8.4.5 Micro Orgo Chem Recent Developments
  25. 8.5 Noramco
  26. 8.5.1 Noramco Company Information
  27. 8.5.2 Noramco Business Overview
  28. 8.5.3 Noramco Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Noramco Buprenorphine Hydrochloride Injection Product Portfolio
  30. 8.5.5 Noramco Recent Developments
  31. 8.6 Resonance-labs
  32. 8.6.1 Resonance-labs Company Information
  33. 8.6.2 Resonance-labs Business Overview
  34. 8.6.3 Resonance-labs Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Resonance-labs Buprenorphine Hydrochloride Injection Product Portfolio
  36. 8.6.5 Resonance-labs Recent Developments
  37. 8.7 Rusan Pharma
  38. 8.7.1 Rusan Pharma Company Information
  39. 8.7.2 Rusan Pharma Business Overview
  40. 8.7.3 Rusan Pharma Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Rusan Pharma Buprenorphine Hydrochloride Injection Product Portfolio
  42. 8.7.5 Rusan Pharma Recent Developments
  43. 8.8 Siegfried
  44. 8.8.1 Siegfried Company Information
  45. 8.8.2 Siegfried Business Overview
  46. 8.8.3 Siegfried Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Siegfried Buprenorphine Hydrochloride Injection Product Portfolio
  48. 8.8.5 Siegfried Recent Developments
  49. 8.9 Sun Pharma
  50. 8.9.1 Sun Pharma Company Information
  51. 8.9.2 Sun Pharma Business Overview
  52. 8.9.3 Sun Pharma Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharma Buprenorphine Hydrochloride Injection Product Portfolio
  54. 8.9.5 Sun Pharma Recent Developments
  55. 8.10 Unichemlabs
  56. 8.10.1 Unichemlabs Company Information
  57. 8.10.2 Unichemlabs Business Overview
  58. 8.10.3 Unichemlabs Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Unichemlabs Buprenorphine Hydrochloride Injection Product Portfolio
  60. 8.10.5 Unichemlabs Recent Developments
  61. 8.11 Sanofi
  62. 8.11.1 Sanofi Company Information
  63. 8.11.2 Sanofi Business Overview
  64. 8.11.3 Sanofi Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi Buprenorphine Hydrochloride Injection Product Portfolio
  66. 8.11.5 Sanofi Recent Developments
  67. 8.12 Teva
  68. 8.12.1 Teva Company Information
  69. 8.12.2 Teva Business Overview
  70. 8.12.3 Teva Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Teva Buprenorphine Hydrochloride Injection Product Portfolio
  72. 8.12.5 Teva Recent Developments
  73. 8.13 Johnson Matthey
  74. 8.13.1 Johnson Matthey Company Information
  75. 8.13.2 Johnson Matthey Business Overview
  76. 8.13.3 Johnson Matthey Buprenorphine Hydrochloride Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Johnson Matthey Buprenorphine Hydrochloride Injection Product Portfolio
  78. 8.13.5 Johnson Matthey Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Buprenorphine Hydrochloride Injection Value Chain Analysis
  2. 9.1.1 Buprenorphine Hydrochloride Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Buprenorphine Hydrochloride Injection Sales Mode & Process
  6. 9.2 Buprenorphine Hydrochloride Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Buprenorphine Hydrochloride Injection Distributors
  9. 9.2.3 Buprenorphine Hydrochloride Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst